Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Elite Pharms Inc (OP:ELTP)

0.2470 +0.0048 (+1.98%)
Streaming Delayed Price Updated: 3:17 PM EDT, Sep 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 408,703
Open 0.2421
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2422
Today's Range 0.2400 - 0.2480
52wk Range 0.2400 - 0.6943
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Elite Pharmaceuticals Q1 Earnings Call Highlights ↗
Elite Pharmaceuticals (OTCMKTS:ELTP) reported first-quarter fiscal 2027 revenue of $32.4 million and operating profit of $7.5 million, with Chief Financial Officer Carter Ward describing both measures... 
Via MarketBeat
Topics Earnings Supply Chain
News headline image
Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript ↗
Elite Pharmaceuticals (OTC:ELTP) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For... 
Via Benzinga
Topics Earnings

Performance

YTD
-50.6%
-50.6%
1 Month
-14.6%
-14.6%
3 Month
-31.8%
-31.8%
6 Month
-34.6%
-34.6%
1 Year
-60.3%
-60.3%

More News

Read More
News headline image
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Via Newsfile
Topics Intellectual Property
News headline image
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
Via Newsfile
News headline image
Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
Via Newsfile
News headline image
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
Via Newsfile
News headline image
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024
Via Newsfile
News headline image
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
Via Newsfile
News headline image
Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets
Via Newsfile
News headline image
Top Analyst Reports For Nvidia, American Express & Wells Fargo ↗
Via Talk Markets
News headline image
Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
Via Newsfile
News headline image
ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q1 2025 ↗
Via InvestorPlace
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
Via Newsfile
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024
Via Newsfile
News headline image
ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q4 2024 ↗
Via InvestorPlace
News headline image
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information
Via Newsfile
News headline image
Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet ↗
Via InvestorPlace
News headline image
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024
Via Newsfile
News headline image
7 Strong Buy Penny Stocks to Buy Now: June 2024 ↗
Via InvestorPlace
News headline image
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Via ACCESSWIRE

Frequently Asked Questions

Is Elite Pharms Inc publicly traded?
Yes, Elite Pharms Inc is publicly traded.
What exchange does Elite Pharms Inc trade on?
Elite Pharms Inc trades on the OTC Traded
What is the ticker symbol for Elite Pharms Inc?
The ticker symbol for Elite Pharms Inc is ELTP on the OTC Traded
What is the current price of Elite Pharms Inc?
The current price of Elite Pharms Inc is 0.2470
When was Elite Pharms Inc last traded?
The last trade of Elite Pharms Inc was at 09/22/26 03:17 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.